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Abstract
Background: Successfully transferring the findings of expensive and tightly controlled programmes of intensive lifestyle
modification to the primary care setting is necessary if such knowledge is to be of clinical utility. The objective of this study
was to test whether intensive lifestyle modification, shown previously in tightly-controlled clinical trials to be efficacious for
diabetes risk-reduction among high-risk individuals, can reduce cardiovascular risk factor levels in the primary care setting.
Methodology / Principal Findings: The Swedish Bjo ¨rkna ¨s study was a randomized controlled trial conducted from 2003 to
2006 with follow-up on cardiovascular risk factors at 3, 12, 24 and 36 months. A total of 151 middle-aged men and women
at moderate- to high-risk of cardiovascular disease from northern Sweden were randomly assigned to either an intensive
lifestyle intervention (n=75) or control (n=76) group. The intervention was based broadly on the protocol of the Diabetes
Prevention Program. The three-month intervention period was administered in the primary care setting and consisted of
supervised exercise sessions and diet counselling, followed by regular group meetings during three years. The control
group was given general advice about diet and exercise and received standard clinical care. Outcomes were changes in
anthropometrics, aerobic fitness, self-reported physical activity, blood pressure, and metabolic traits. At 36 months post-
randomisation, intensive lifestyle modification reduced waist circumference (22.2 cm: p=0.001), waist-hip ratio (20.02:
p,0.0001), systolic blood pressure (24.9 mmHg: p=0.036), and diastolic blood pressure (21.6 mmHg: p=0.005), and
improved aerobic fitness (5%; p=0.038). Changes in lipid or glucose values did not differ statistically between groups. At 36
months, self-reported time spent exercising and total physical activity had increased more in the intervention group than in
the control group (p,0.001).
Conclusion / Significance: A program of intensive lifestyle modification undertaken in the primary health care setting can
favourably influence cardiovascular risk-factor profiles in high-risk individuals.
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Introduction
Evidence from epidemiological and experimental studies
overwhelmingly illustrates the beneficial impact of healthy lifestyle
behaviours on cardiovascular risk [1–2]. Lifestyle factors such as
physical inactivity, diets rich in saturated fats and sugar, and
central obesity contribute to the development of type 2 diabetes
and cardiovascular disease (CVD) [1–3]. People who maintain
physically active lifestyles have lower levels of most atherosclerotic
and metabolic risk factors [1–3], spend more years free from type
2 diabetes [1], and live longer [1–2]. A low level of cardiorespi-
ratory fitness, which is influenced by physical activity levels, is a
powerful, independent risk factor for premature mortality [1–2].
Regular physical activity is also associated with a reduced risk of
CVD and with reduced rates of cardiovascular and total mortality
in people with type 2 diabetes [1].
A variety of different intervention methods have been used to
increase physical activity levels. These include paradigms involving
individual- or group-level interventions. The methods to promote
physical activity have involved activity feedback using pedometers,
activity counseling, and exerciseprescription [4–6], or moreextensive
lifestyle programs such as those implemented in the Finnish Diabetes
Prevention Study (DPS) [7] and the Diabetes Prevention Program
(DPP) [8]. These more extensive lifestyle intervention programs have
been shown to induce around 5–7% weight loss and consequently
achieve clinically relevant reductions in cardiovascular risk factor
levels [9–10] and delay the onset of type 2 diabetes [7,11–12] and
CVD [1–3]. Exercise interventions can reduce central obesity in a
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5195dose-dependent manner independently of changes in nutrient or
caloric intake [13–14], thus improving CVD risk profiles [14–15]. In
people with type 2 diabetes, both structured exercise training [16–19]
and physical activity counseling [20–21] result in weight loss and
improved metabolic homeostasis. Although weight loss certainly
mediates many of the beneficial effects of exercise on type 2 diabetes
risk reduction, exercise may also prevent or delay the onset of type 2
diabetes through independent mechanisms [22] involving insulin
signaling, glucose and lipid oxidation, and reduced hepatic glucose
production.
Although a number of randomized controlled trials have
successfully demonstrated the efficacy of intensive lifestyle
intervention for cardiovascular [23–25] and type 2 diabetes [11–
12] risk reduction, to our knowledge only a few attempts to apply
the protocols used in these studies for lifestyle modification in the
primary health-care setting have been documented [26–27], none
of which were randomized or involved long-term follow-up.
We recently reported the provisional results (at 12 months
follow-up) of a randomized controlled trial, where individuals at
moderate- to high-risk of cardiovascular disease were randomly
assigned to receive either intensive lifestyle modification or
standard care [28]. In that study, which was run from a primary
health-care centre in northern Sweden, we were able to
demonstrate that lifestyle modification improves cardiovascular
risk factor levels. The intervention was group-based, focusing on
aerobic and resistance training, improvements in dietary habits,
motivation, and maintenance of behavioral changes, and was
carried out without additional resources at a primary-care centre.
In this report from the same clinical trial, we describe the overall
trial results from baseline through three years follow-up.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
The Swedish Bjo ¨rkna ¨s Study was a randomized controlled
clinical trial. Participants assigned to the control arm of the study
received standard care and those assigned to the intervention arm
received a program of lifestyle modification including structured
exercise training sessions and diet counselling. Individuals were
followed-up at 3, 12, 24 and 36 months (Figure 1.)
Participants
Thestudypopulationwasselected fromthe catchmentareaofthe
Swedish Bjo ¨rkna ¨s primary health care center in the town of Boden
in northern Sweden. Participants were enrolled in the study by the
medical supervisor of the health care at the center. All individuals
aged 18–65 years with a clinically documented diagnosis of
hypertension, dyslipidemia, type 2 diabetes, obesity or any
combinations thereof were identified from computerised case
records. Individuals with a diagnosis of coronary heart disease,
stroke, transient ischemic attack, severe hypertension (SBP.180 or
DBP.105 mmHg), dementia or severe psychiatric morbidity were
excluded. The remaining 340 eligible individuals were invited by
letter to participate in the trial (Figure 1). Of those, 177 individuals
agreed to participate (52% of those eligible); 18 withdrew before
randomisation,andafurthereightmet the study’sexclusioncriteria.
Randomization
A total of 151 enrolled participants were randomly allocated
using a computer-generated random numbers sequence to the
intervention group (n=75) or the control group (n=76). An
independent statistician generated the allocation sequence and
randomisation numbers were kept in sealed, opaque envelopes. The
allocation was concealed until after the baseline examinations were
completed and participants were assigned to their groups by the
research physiotherapist. After excluding four subjects who were
allocated to the lifestyle intervention but did not start the
intervention period, and excluding two subjects with incomplete
baselinedata allocated to control group, the numbers ofparticipants
were 71 and 74 in the intervention and control groups, respectively.
Ethics
All participants provided written informed consent to partici-
pate and the study protocol was approved by institutional review
board of Umea ˚ University, Sweden.
Clinical examination
At each examination, measurements of weight, height, circum-
ferences of the waist and hips, blood pressure by a standard
auscultatory method, and an estimate of maximal oxygen uptake
(VO2max) were obtained. Body mass index (BMI: weight in kg /
height in meters squared) and waist-to-hip ratio were calculated.
VO2max was estimated as described by A ˚strand [29] from each
participant’s individual heart rate response to a given submaximal
workload (i.e. 50–150 W, depending on the participant’s weight
and self-reported physical activity) using a bicycle ergometer
(Monark, Varberg, Sweden) and recorded at steady-state with a
heart rate of $120 beats/min. In the original test A ˚strand
reported a correlation of r=0.78 between estimated and measured
VO2max [29]. Other authors have reported correlations within
the range r=0.69–0.95, varying by age and gender. The method
has also proven reliable when repeated measures are available
within the same individual [30].
A history and physical exam was undertaken at baseline focusing
oncardiovascular diseaseandcurrentmedicationusage.Changesin
pharmacological treatmentwerefollowed yearly.A trained research
physiotherapist (ME) performed all interviews and undertook the
anthropometric and blood pressure measurements to minimize
observer bias. Two other trained physiotherapists performed the
exercise stress tests. The physiotherapists were not blinded to
allocation of treatment at the follow-up examinations.
Laboratory measurements
The methods for blood collection, storage and analysis have been
described in detail previously [28]. In brief, total cholesterol and
triglycerides were analysed by enzymatic colorimetry (slide method,
Vitros 5.1.Ortho-Clinical diagnostics, Raritan, New Jersey). High-
density lipoprotein cholesterol (HDL-C) was analysed by enzymatic
(dextran sulfate procedure) colorimetry (Hitachi 917, Roche
Diagnostics Scandinavia AB, Bromma, Sweden). Low-density
lipoprotein (LDL) cholesterol was calculated using the Friedwald
equation. Serum glucose was analysed by enzymatic (glucose
oxidase) colorimetry (Vitros 5.1, Ortho-Clinical Diagnostics,
Raritan, New Jersey). Glycosylated haemoglobin (Hb) A1c was
analysed by High Performance Liquid Chromatography, Ion
exchange Chromatography, Photometry (VARIANT
TMII, BIO-
RAD laboratories, Hercules, California). All biochemical analyses
were performed at the clinical chemistry laboratory at Sunderby
Hospital, Lulea ˚, Sweden. All non-diabetic participants underwent a
75 g oral glucose tolerance test, using the protocol recommended by
the WHO, at two and three years post-randomisation.
Behaviour assessments
Physical activity and tobacco habits were assessed using a self-
administered questionnaire, previously used in the national project
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Public Health [31]. The questionnaire has also been used by a
number of Swedish regional health authorities to assess public
health within the community. However, no validation studies have
been performed for this questionnaire. The questionnaire is
intended to characterise a participant’s levels of leisure time
activity (LTPA), structured exercise, and total physical activity
(TPA). LTPA includes activities such as housekeeping, gardening,
walking or biking to work, and ‘exercise’ includes structured
activities such as aerobics, jogging, swimming, and ball games
carried out during a normal week. Four activity levels were
determined for LTPA and exercise; ‘none’, ‘,30 min/d’, ‘30–60
Figure 1. Participants flow Diagram.
doi:10.1371/journal.pone.0005195.g001
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that were intended to estimate all forms of physical activity
undertaken during the past 12 months. A TPA index with four
activity levels was constructed: ‘sedentary’, ‘minimally active’,
‘moderately active’, and ‘very active’. Participants in both groups
were also requested to complete physical activity logs.
Interventions
The lifestyle intervention consisted of supervised exercise
training and diet counselling, followed by regular group meetings.
The first three months of the intervention included three sessions
per week of supervised progressive exercise training and diet
counselling on a total of five occasions. The exercise training
sessions consisted of aerobic exercises such as Nordic walking
(brisk walking with poles), interval training on a bicycle ergometer,
circuit-type resistance exercise, and aqua-aerobics. These activities
were led by physiotherapists and physiotherapy assistants at the
primary care centre. The physiotherapists were responsible for
both the clinical examinations and delivering the exercise
intervention. Exercise training was performed in small groups
(n=10–13) with each group comprising participants of similar
ages and fitness levels. All groups were offered one session of each
activity every week. The exercise training sessions lasted 40–45
min during the first month and increased to 60 min during the
second and the third months. The duration of the bicycle
ergometry exercise was increased from 20 min to 30 min after
one month. The resistance training consisted of 12 different
movements per circuit: two sets of 10–15 repetitions were
performed at each station. The load was individualized and
increased over time as the participant’s strength improved. All
programmes included a warm-up and a cool-down period with
stretching. The aim of the exercise sessions was to increase
cardiorespiratory fitness and to improve functional capacity and
strength of the large muscle groups of the arms, torso and legs. To
approximate optimal exercise intensity, the Borg scale of perceived
exertion was used [32]. A moderate intensity (60–80% of maximal
heart rate) corresponding to 13–15 on the Borg scale was
recommended for all activities.
A trained dietician was responsible for the diet counselling. The
dietary advice was given in small groups but no individual
counselling was provided. The participants received both written
and verbal dietary information. The counselling was in accordance
with the Nordic nutrition recommendations [33]. Briefly the
participants were encouraged to increase their intake of fish, fruits,
vegetables fibre-rich products and complex carbohydrates. Partic-
ipants were also advised to restrict total caloric intake by reducing
consumption of sugar and saturated fat and to use low-fat milk
products, soft margarines and vegetable oils rich in monosaturated
fatty acids (See table 1).
After the active intervention period, participants from each
training group were invited to attend regular follow-up meetings
on six occasions during the first year (from September to
February), on four occasions during the second year and on two
occasions during the third year (Figure 1). The objectives of the
follow-up meetings were (i) to improve the participant’s knowledge
about the relationships between lifestyle and health, (ii) to
encourage participants to favourably modify their lifestyles, and
(iii) to provide social support and to facilitate adherence to the
intervention. The stages-of-change model of behavioural change
was used as theoretical basis for the intervention [34]. The
techniques used were standardized for all participants. After the
active intervention period most individuals were in the ‘prepara-
tion’ or ‘action’ phases. Participants were asked to investigate
benefits, barriers, and costs of adherence to a healthier lifestyle and
were encouraged to establish individual goals for weight reduction
and to develop a personal physical activity plan. They were
encouraged to maintain at least 30 min/day of physical activity.
Participants also received information about community-based
physical activity and a study visit at a local gym was provided for
each training group.
At the group meetings discussions focussed on physical activity,
diet, coping with stress, and the effects of tobacco on health. The
progress of each participant was discussed at the meetings during
the follow-up period. Emphasis was placed on identifying
situations that inhibit healthy behaviours such as holidays or
heavy workloads and strategies to handle these situations were
discussed. During the final stage of the trial, the importance of
maintaining healthy habits and on avoiding relapses was
reinforced.
Physiotherapists supervised most of the in-person meetings, and
a dietician provided further diet counselling on three occasions,
once each year during the follow-up period. The medically
responsible physician took part in one meeting at the beginning of
the study and one at the end of the study to answer participants’
questions about the health aspects of the intervention and to
reinforce the messages being delivered by the physiotherapists and
the dietician.
Participants in the standard care control group were given
verbal and written information about healthy behaviours,
including exercise and diet. This information was delivered by
the physician, a physiotherapist and a dietician at a group meeting
following the baseline examination (Figure 1).
Blinding
Neither the participants nor the family practitioners or
physiotherapists who delivered the intervention were blinded to
the allocation of treatment. Each year, participants in both groups
were given a written summary of their laboratory and clinical test
results. Participants in both groups continued with their routine
care, delivered for example by their family practitioner or
specialist, throughout the study, and no special instructions were
given regarding other preventive measures.
Objectives
Our objective was to test the hypothesis that a lifestyle
intervention program in the primary health care setting facilitates
long-term (up to 3 yrs) clinically relevant improvements in
cardiovascular and metabolic risk profiles in people who, at
baseline, were at high risk of cardiovascular disease.
Outcomes
Outcome measures were changes in anthropometry (BMI,
weight, waist, waist-to-hip ratio), VO2max, self-reported physical
activity, blood pressure, triglycerides, cholesterols (total, HDL, and
LDL), fasting blood glucose, glucose tolerance, and HbA1c.
Sample size
In the DPP, weight loss at 1 and 3.4 years within the lifestyle
intervention group averaged 6.8 kg and 4.1 kg, respectively [33].
For sample size calculations, we assumed 20% of participants from
our study would withdraw before completion, and that our
intervention would yield approximately half the weight loss at
three years post-randomisation than observed in the DPP (i.e. 2.1
kg, SD 61 kg). We also assumed that because the control group
was receiving standard health advice and was not blinded to
treatment allocation, those in that group would lose up to 1 kg (SD
61 kg) in weight during the trial. We selected a two-sided p-value
The Swedish Bjo ¨rkna ¨s Study
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parameters, our study was powered at ,99% to detect the
predicted difference in weight change between groups at 3 years
follow-up. Power was calculated using STATA v9.2 SE (Stata-
Corp, TX, USA)
Statistical methods
SPSS for Windows (v15.0, Chicago, IL) and SAS for Windows
(V9.1, Carey, NC) were used for all statistical analyses. Data were
analysed on an intention-to treat (ITT) basis, regardless of
adherence to the intervention and included all randomly allocated
persons, with the exception of the six individuals excluded for the
reasons given above (Figure 1). If data were missing, the last
observation was carried forward.
Generalized linear models with repeated measures analysis of
variance and univariate tests of variance were used to investigate
changes in the dependent variables (as continuous traits) over time
at each of the follow-up time points, adjusted for baseline values.
To determinate the independent effects of the intervention on
blood pressures, lipids, or HbA1c, these variables were adjusted for
‘‘medication load’’. To this end, a variable was computed from the
number of specific drugs prescribed to treat the respective trait by
assigning values of 1 for low doses and 2 for high doses and
subsequently summing these values.
Ancillary analyses
Mixed-model analyses were used to calculate the adjusted
effects of the intervention at each of the follow-up points for
continuous trait outcomes and to investigate the overall effect of
the intervention. The mixed-model included all available follow-
up data. To account for multiple observations within individual,
models were fitted using an unstructured covariance matrix. The
choice of matrix was determined by comparing Akaike’s
Information Criterion for different structures and selecting the
matrix that best fitted the data. This method allows for trait
correlations between different examinations within the same
individual. The results of these models indicate whether changes
in the values of a trait from baseline to follow-up differ significantly
Table 1. Summary of physical activity and diet recommendations provided to participants randomized to the control and
intervention groups.
Control group (standard recommendations) Intervention group (extended recommendations)
Physical activity - Aim to accumulate at least 30 minutes of
moderate-intensity physical activity on most,
preferably all, days of the week
- Aim to accumulate at least 30 minutes of moderate-intensity
physical activity on most, preferably all, days of the week
Swedish Institute of Public Health - Additional health benefits can be achieved by
extending the time spent in moderate-intensity
activities, or by increasing the intensity of actives
- Additional health benefits can be achieved by extending the time
spent in moderate-intensity activities, or by increasing the intensity
of actives
- Aim to undertake 20–30 minutes of moderate to vigorous
intensity of aerobic activities lasting 20–30 minutes, three times
each week (e.g. bicycle ergometry exercise, Nordic walking, aqua-
aerobics)
- Aim to undertake muscle-strengthening activities, lasting 20–30
minutes, at least twice each week (e.g. circuit-type resistance
exercise, aqua-aerobics)
Diet Energy percent, E%, Energy percent, E%,
- Carbohydrates, 55% (50–60) - Carbohydrates, 55% (50–60)
National food administration sugar ,10% sugar ,10%
- Protein, 15% (10–20) - Protein, 15% (10–20)
(NNR) - Fat, 30% (25–35) - Fat, 30% (25–35)
saturated fat and trans fat, 10% saturated fat and trans fat, 10%
monounsaturated fat, 10–15% monounsaturated fat, 10–15%
polyunsaturated fat, 5 (210) polyunsaturated fat, 5 (210)
General advice: General advice:
- Increase intake of fish, fruits, vegetables, fibre rich
products and complex carbohydrates.
- Increase intake of fish, fruits and vegetables, fibre rich products
and complex carbohydrates.
- Reduce consumption of sugar and saturated fat. - Reduce consumption of sugar and saturated fat.
- Use low-fat milk products, soft margarines and
vegetable oils rich in monosaturated fatty acids.
- Use low-fat milk products, soft margarines and vegetable oils rich
in monosaturated fatty acids.
- Restrict total caloric intake. - Restrict total caloric intake.
- Regular meal distribution. - Regular meal distribution.
Information about meal content and function of:
- Fat, carbohydrates, protein, vitamins, minerals and antioxidants.
- Energy balance and energy expenditure.
- Alcohol.
Cooking advise
doi:10.1371/journal.pone.0005195.t001
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fixed effects, the mixed-model estimates components of variance
(random effects) representing the relation between different
observations for the same individual. For continuous or rank-
ordered data, the parameters of these variables were estimated by
a maximum-likelihood procedure. For ordinal data such as those
obtained from questionnaires, the non-parametric Mann-Whitney
U test was used for analysis between groups at each follow-up time
point, and mixed-models were used to assess the overall effects of
the intervention. For other discrete variables, the Pearson Chi-
Square test and repeated measures analysis were used. A p-value
,0.05 was considerer statistically significant.
Results
Recruitment
Participants were recruited in January 2003 and underwent
baseline examinations in February 2003. Follow-up examinations
were conducted 3, 12, 24 and 36 months after the baseline
examination. The study was completed in March 2006.
Participants flow
From the original 151 volunteers, a total of 120 completed the
3-year follow-up examination (80%); n=58/75 in the intervention
group and n=60/76 in the control group. Attrition was greatest
during the first year of the study, attributed mainly to ill health,
heavy workloads, or relocation to another geographic region
during follow-up (Figure 1).
Subject characteristics
There were no differences in demographic characteristics or
CVD risk profiles between study participants and the 163 subjects
who declined to participate. Mean age in the study group was 54.4
vs. 51.8 years in the group of non-participants. Gender
distribution and the prevalence of risk factors were similar. In
the study group 43% were male, 66% had a diagnosis of
hypertension, 28% had a diagnosis of type 2 diabetes, and 22%
had dyslipedemia. The corresponding proportions among those
who did not participated were male 50%, hypertension 69%, type
2 diabetes 32%, and dyslipidemia 18%. Of all eligible subjects
about half had at least one CVD risk factor and a third had two or
more CVD risk factors besides being overweight or obese. Only 40
of the 340 individuals had ‘‘overweight’’ or ‘‘obesity’’ recorded as
clinical diagnoses in their case records, which were an underes-
timate of the true prevalence of these conditions (see Table 2).
In the intervention group 12 women and 5 men withdrew,
compared with 5 women and 9 men in the control group. Mean
age at recruitment among individuals who withdrew was 53.2
years, which was not statistically different from those who
completed the trial (mean age 55.2 years). In both groups the
individuals who withdrew were obese or overweight, with one or
two additional CVD risk factors. Those who withdrew before
randomisation due to employment commitments were somewhat
younger (mean age 49.7 years) and most were female and had
irregular working hours. In contrast, subjects who withdraw due to
illness were older (mean age 61.8 years).
Compliance
Seventy percent of the intervention group attended the
supervised exercise sessions during the three-month intervention
period, but varied from 15% to 100% across sessions. Sixty-four
percent took part in 3–5 diet-counselling sessions but 36%
participated on only one or two occasions. Low attendance was
mainly due to employment commitments. During the first year of
the trial mean attendance at the follow-up meetings was 70%,
during the second year 63% and at year three 66%. Seventy-seven
percent of the control group attended the information meeting
about lifestyle and health (Figure 1). Participants in both groups
were asked to complete activity logs during the trial. Of the 120
participants who completed the 3-year follow-up examination,
60% of the intervention group completed activity logs during the
first year, 40% during the second year and 31% during the third
year. In the control group the corresponding proportions were
46%, 38% and 29%.
Baseline data
Although participants were randomly assigned to the study
arms, not all characteristics were distributed equally between the
control and intervention groups. As shown in Table 2 and Table 3,
at baseline participants in the intervention group tended to have
larger waists, undertook less LTPA and were more frequently
treated with lipid lowering drugs than those in the control group.
Numbers analysed
All data analyses were performed on an ITT basis. Accordingly,
if data were missing, the last observation was carried forward.
Analyses included 71 participants from the intervention group and
74 participants from the control group, except in analyses of
fasting blood glucose, HbA1c and VO2max (Table 2). Fasting
blood glucose concentrations were analysed only in participants
without known diabetes and HbA1c was analysed in participants
with diagnosed diabetes. Participants on beta-blockers were
excluded from analyses where VO2max was the outcome, as the
heart rate response to exercise (a necessary component of the
VO2max prediction equation) is blunted with this type of
medication.
Outcomes and estimation
At baseline, the proportions of normal weight, overweight and
obese individuals in the intervention group were 10%, 45% and
45%, respectively; in the control group, the corresponding
proportions were 16%, 43% and 41% (Table 2). Improvements
in anthropometric characteristics were evident in both groups at
three years post-randomisation, although improvements were
generally greater in the intervention group (Figure 2). Statistically
significant reductions in weight between groups were observed at
the 3-month follow-up exam. The proportion of participants
classified as normal weight (i.e., BMI 20–24.9 kg/m
2) in the
intervention group increased from 10% (n=7) to 17% (n=12)
during the 36 months of the trial, although this change did not
differ significantly from the control group.
The reduction in waist circumference (ITT p=0.001; mixed
model p,0.0001) and waist-to-hip ratio (ITT p,0.0001; mixed
model p,0.0001) was greater in the intervention group than in the
control group. Values in the intervention group were lower at each
follow-up point (Figure 2). At 36 months post-randomisation, waist
circumference (22.2 cm) and waist-to hip ratio (20.02) had
decreased in the lifestyle intervention group. In the control group
waist circumference was 102.9 cm (95%CI 101.87–103.92) at 3-
year, and in the intervention group 100.7 cm (95% CI 99.65–
101.74). No change was noted in hip circumference (p=0.178)
(mixed-model p-value 0.36).
Reductions in systolic (ITT p=0.03; mixed model p=0.0062)
and diastolic (ITT p=0.005; mixed model p=0.0004) blood
pressures were greater in the intervention group than in the
control group, after adjustments for baseline values and medica-
tion load. Systolic blood pressure was significantly lower (24.9
mmHg) in the intervention compared with the control group after
The Swedish Bjo ¨rkna ¨s Study
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Characteristic Intervention group (n=71) Control group (n=74)
Age, yr, mean (SD) 55.7 (6.6) 53.1 (8.2)
Sex, No. (%)
Male 35 (49) 27 (36.5)
Female 36 (51) 47 (63.5)
Non-smokers, No. (%) 54 (76) 61 (82)
Ex-smokers, No. (%) 24 (34) 29 (39)
Anthropometrics, mean (SD)
Body weight, kg 87.4 (16.5) 84.3 (20.0)
Body Mass Index, Kg/m
2 { 30.2 (5.2) 29.4 (5.1)
Waist circumference, cm 104.1 (13.2) 100.2 (15.9)
Hip circumference, cm 108.6 (10.2) 107.4 (8.6)
Waist-to-hip ratio 0.96 (0.08) 0.93 (0.09)
Presence of overweight or obesity, No. (%)
Body Mass Index 25–29,9 32 (45) 32 (43)
Body Mass Index $30 32 (45) 30 (41)
Blood pressure, mean (SD)
Systolic, mmHg 146 (15.5) 145 (17.6)
Diastolic, mmHg 88 (7.1) 87 (8.4)
Cardiovascular risk factors, mean (SD)
Total Cholesterol, mmol/l 5.49 (1.05) 5.43 (0.91)
High Density Lipoprotein Cholesterol, mmol/L 1.39 (0.32) 1.46 (0.40)
Low Density Lipoprotein Cholesterol, mmol/L 3.17 (0.91) 3.12 (0.82)
Triglycerides, mmol/l 2.08 (1.24) 1.90 (1.15)
Fasting-blood glucose, mmol/L { 5.24 (0.50) 5.20 (0.50)
HbA1c (%) 1 6.30 (1.35) 6.62 (2.05)
Type 2 diabetes, No. (%) 23 (32) 17 (23)
Exercise test variables, mean (SD)
Maximal Oxygen uptake, VO2 , L/min " 2.1 (0.6) 2.2 (0.5)
Maximal Oxygen uptake, VO2 , mL/kg per minute " 25.4 (6.4) 25.8 (6.0)
Total physical activity, No. (%)
Sedentary 14 (20) 3 (4)
Minimally active 27 (38) 35 (47)
Moderately active 22 (31) 25 (34)
Very active 8 (11) 11 (15)
Exercise, No. (%)
None 43 (61) 37 (50)
,30 min/d 20 (28) 22 (30)
30–60 min/d 8 (11) 13 (18)
.60 min/d 0 (0) 2 (3)
Leisure-time activity, No. (%)
None 14 (20) 5 (7)
,30 min/d 23 (32) 25 (34)
30–60 min/d 30 (43) 29 (39)
.60 min/d 4 (6) 15 (20)
*Age and anthropometric, clinical and metabolic data are given as mean (SD); for other variables data are given as the number of observations (%).
{Calculated as weight in kilograms divided by the square of height in meters.
{n=49/57.
1n=22/17 only in known diabetics.
"n=50/42.
doi:10.1371/journal.pone.0005195.t002
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mean 146.8 mmHg; 95%CI 144.2–149.4 mmHg). Diastolic blood
pressure was significantly lower in the intervention group at all
time points except at three years (Figure 3). During follow-up, the
use of blood pressure lowering drugs increased in both groups; this
increase did not differ between groups (Table 3).
No significant differences in lipid variables were observed
between groups during follow-up (Figure 4). The medication load
of lipid lowering drugs was higher in the intervention group than
in the control group at all time points (Table 3).
In participants with known diabetes, no differences between
groups were observed in HbA1c levels or medication usage during
follow-up and no differences between groups were observed in
fasting-blood glucose levels in participants without known diabetes
(Figure 4). However, one new clinical diagnosis of diabetes
occurred in the control group and none was observed in the
intervention group. An OGTT was carried out at the examina-
tions after 2 and 3 years. The prevalence of impaired glucose
tolerance and diabetes diagnosed by OGTT tended to be lower in
the intervention group (24%) than in the control group (34%),
although these proportions were not statistically different (Table 3).
After an initial improvement in estimated maximal oxygen
uptake in both groups, which was greatest in the intervention
group (VO2max 0.3 l/min; p=0.006, 4.0 ml/kg/min; p,0.001),
a gradual decline toward baseline values was observed during
follow-up (Figure 3). In the ITT analysis, the improvement by
study end in estimated maximal oxygen uptake was greater in the
intervention group (VO2max 2.2 l/min; 95% CI 2.11–2.29) than
in the control group (VO2max 2.1 l/min; 95% CI 2.00–2.19)
when expressed in absolute terms (p=0.038), although not when
expressed relative to body mass (VO2max 26.0 ml/kg/min;
95%CI 25.0–26.9 v s 25.0 ml/kg/min; 95% CI 24.0–26.1)
(p=0.061). In the mixed model analysis, the differences in
VO2max reflected those observed in the ITT analyses (VO2max
l/min: p=0.049; VO2max ml/kg/min: p=0.12).
The improvements in VO2max may reflect an effect of
increased physical activity levels in participants in the intervention
group; those individuals reported more exercise participation
(p,0.0001) and greater TPA (p,0.0001) compared with partic-
ipants in the control group by the end of the trial. At baseline 20%
of the lifestyle intervention group was sedentary, whereas only 7%
was sedentary at the 3-year examination. At three years about
70% of both groups reported LTPA of at least 30 min/d, but in
the intervention group the proportions of those reporting being
moderately or very physical active had increased from 42% to
59%, respectively. This contrasted the control group, where
Table 3. Changes in medication treatment and cigarette smoking from baseline to 3 years follow-up in the Swedish Bjo ¨rkna ¨s
study*.
Characteristic
Intervention group
(n=71) {
Control group
(n=74) { P-Value{ P-value 1
Current cigarette smoking, No. (%)
Baseline 17 (24) 13 (18) 0.34
3 month 16 (23) 13 (18) 0.46
1 year 14 (20) 13 (18) 0.74
2 years 12 (17) 13 (18) 0.92
3 years 10 (14) 12 (16) 0.72 0.04
Hypertension, medication load 0–7, M (SD)
Baseline 1.42 (1.58) 1.50 (1.50) 0.45
3 months 1.44 (1.61) 1.49 (1.53) 0.50
1 year 1.58 (1.77) 1.62 (1.61) 0.61
2 years 1.75 (1.80) 1.82 (1.63) 0.30
3 years 1.90 (1.88) 1.88 (1.69) 0.63 0.65
Dyslipidemia, medication load 0–2, M (SD)
Baseline 0.39 (0.60) 0.15 (0.46) 0.002
3 months 0.39 (0.60) 0.18 (0.48) 0.011
1 year 0.46 (0.61) 0.20 (0.52) 0.001
2 years 0.51 (0.58) 0.23 (0.54) 0.000
3 years 0.55 (0.58) 0.28 (0.63) 0.000 0.41
Diabetes mellitus and Impaired glucose tolerance at Oral glucose
tolerance test, No.(%)
2 years " 9 (24) 15 (31) 0.52
3 years ¥ 9 (24) 16 (33) 0.37
*Data are given as the number of observations (%) or mean (SD).
{Last observation carried forward for individuals who withdrew. Number of participants at 3 months: IG=66, CG=69. n at 1 year IG=60, CG=63. Number of participants
at 2 years: IG=58, CG=63. n at 3 year IG=58, CG=62.
{P- value for difference between groups generated using the Pearson Chi-Square test.
1P- value generated using a general linear model with repeated measures.
"IG/CG n=37/49.
¥IG/CG n=37/48.
doi:10.1371/journal.pone.0005195.t003
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Correspondingly, in the intervention group the proportion
reporting exercising at least 30 min/d or more increased from
11% to 28% (Figure 5). The results from the mixed-model analyses
were consistent with the ITT analyses for both exercise (p,0.001)
and TPA (p=0.0009).
The proportion of individuals who quit smoking in the
intervention group (41%) was significantly greater than in the
control group (8%) (p=0.04) (Table 3).
Adverse advents
No adverse events (i.e. fractures, sprains, or serious cardiovas-
cular events associated with exercise) were reported by participants
during the study.
Discussion
We present here the full results from the Swedish Bjo ¨rkna ¨s
Study, a three year randomised controlled trial of intensive lifestyle
modification for cardiovascular risk reduction in patients at
moderate- to high-risk of cardiovascular disease. The study
protocol was adapted from the DPP, but was delivered with
limited resources at a primary health care centre in the northern
Swedish town of Boden. The lifestyle intervention favourably
impacted physical activity and aerobic fitness, waist circumference,
waist-to hip ratio, blood pressure, and smoking cessation. No effect
of the intervention was observed on glycaemia or lipidaemia.
Being obese or having diabetes diminishes quality of life [35–36]
and imposes considerable economic burdens on health care
systems [35]. Thus, interventions that beneficially impact
cardiovascular risk-factor levels in high-risk individuals are likely
to improve individual well-being, may be more cost-effective than
population-wide lifestyle modification strategies [37], and safer
and less expensive than drug therapy [38]. Several large-scale
intervention studies during the past decade have illustrated the
efficacy of lifestyle intervention for diabetes risk reduction. In the
DPP [8] and the Finnish DPS [7], the reduction in diabetes risk
attributable to lifestyle modification was 58% in both studies using
ITT analyses. The DPP authors predicted that in individuals with
similar characteristics to the DPP volunteers, seven would need to
participate in a similar lifestyle intervention program to prevent
one case of diabetes during a 3-year follow-up period [8]. In the
DPP, the level of diabetes risk reduction in people who met the
goals for weight loss, physical activity and diet modification was
89% [39]. Other reports from the DPP have highlighted the
beneficial impact of lifestyle modification on other cardiovascular
risk factors including glucose homeostasis, insulin sensitivity, lipid
levels, inflammation, coagulation, and obesity [40]. These
observations illustrate the remarkable potential of lifestyle change
for diabetes and cardiovascular risk reduction.
Notwithstanding the considerable health benefits conferred by
the DPP lifestyle intervention, the protocol was costly and, as
delivered in the DPP, beyond the scope of many primary health
care agencies (for further details, see: www.bsc.gwu.edu/dpp/
lifestyle/dpp_part.html). The within-trial costs of the DPP lifestyle
intervention totalled $24400 (USD) per case of diabetes prevented
or delayed [41]. By the conclusion of the initial intervention
period, the running costs of the DPP had totalled $174.3 million
(USD) (http://www.nlm.nih.gov/databases/alerts/diabetes01.
html). An important and hitherto largely unanswered question is
whether the DPP protocol of lifestyle intervention is effective
outside a tightly controlled and well-funded setting of an
extensively supported multi-centre randomised clinical trial.
Although a small number of studies have attempted to address
this question [42–43], all were non-randomised and none was
carried out in the primary care setting with long-term follow-up.
Interpretation
In an earlier publication from the Swedish Bjo ¨rkna ¨s Study we
reported the interim (one year) results of the trial [28]. We
presented crude between-group comparisons showing favourable
effects on waist circumference, waist-hip-ratio and diastolic blood
pressure. In the present report, we show that through reductions in
central obesity, physical activity and smoking cessation, the
lifestyle intervention also favourably impacted blood pressure
levels. However, we did not observe improvements in glycemic
control or weight reduction, which contrasts the results from the
DPP and Finnish DPS. The lack of impact on glucose homeostasis
in the present study may be explained by the relatively modest
level of weight loss observed here and the close biologic
relationship between weight and glucose concentrations.
We observed a significant improvement in VO2max during the
first three months of the trial. At 3 years the improvement in
VO2max persisted only when expressed in absolute terms but not
when expressed per unit body mass. This difference is likely to
reflect the fact that when VO2max is expressed relative to weight,
changes inVO2maxareinfluenced bychangesinbody mass. This is
partly because muscle is a highly oxidative tissue type, whereas
adipose tissue is not. Thus changes in weight and in body
composition impact aerobic capacity differently depending on
whether the trait is expressed relative to weight or in absolute terms.
Reductions in waist circumference were observed in the absence
of reductions in weight, which is consistent with results from other
exercise studies [44]. Moreover, we observed no discernable impact
of the intervention on lipid levels, which is consistent with the
findings of other studies [9,11,17,44–45]. However, in this study,
lipid-lowering treatment was common and baseline lipid levels were
consequently close to target levels, which may have masked any
subtle changes in lipids resulting from the intervention.
We calculated the power available in our study to detect the same
level of change infastingglucose and HbA1cthat was observed one-
year post-randomisation in the DPP. In our study, the power to
detect these changes was approximated 95% for changes in fasting
glucose concentrations and 67% for changes in HbA1c at p,0.05.
However, although this study was well powered to detect a clinically
and statistically significant change in body weight, the magnitude of
this change was less than the average amount of weight lost in the
DPP. One would anticipate, therefore, that in the present study any
effect of lifestyle intervention on fasting glucose levels or HbA1c
would also be less, which likely explains the lack of effect on these
traits observed here.
Generalizability
One of the most important findings of the present study is that a
program of lifestyle modification, using the core features of the
DPP and Finnish DPS, can reduce cardiovascular risk factor levels
Figure 2. (A–D) Changes in anthropometrics. Data are adjusted means (95% confidence intervals) for each time point derived from generalised
line ar models with repeated measures. Adjustments are made for the baseline value for the respective outcome variable. Blood pressure values are
also adjusted for medication load. Statistical significance at each follow-up time point generated from univariate analysis of variance, * p,0.05, **
p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0005195.g002
The Swedish Bjo ¨rkna ¨s Study
PLoS ONE | www.plosone.org 10 April 2009 | Volume 4 | Issue 4 | e5195The Swedish Bjo ¨rkna ¨s Study
PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5195in at-risk adults, even when applied in the conventional primary
care setting, without additional resources. However, it is worth
highlighting that although our cohort is likely similar in
demographic characteristics to the cohorts enrolled in the Finnish
DPS, which yielded comparable results to the DPP, the population
in the northern part of Sweden is culturally and ethnically different
from the cohorts enrolled into the DPP. It is also important to
highlight that participants in the present study were invited by
health care providers from their own health care centres to
participate in this study, which may have facilitated recruitment
rates. For example, more than half of those eligible to participate
in our study were eventually randomised to treatment. By contrast,
in a recent report from the same region of Sweden in which
advertisements were used to recruit participants for a similar
lifestyle intervention program, only 16 % of eligible individuals
agreed to participate [46]. Thus, our strategy of recruiting through
the established health care infrastructure may be fundamental to
the success of our project and others that may follow.
It is also important to bear in mind that, as in all other lifestyle
intervention trials, neither the participants nor the study staffs in
this study were blinded to the allocation of treatment. Thus it is
possible that placebo effects explain some of the beneficial changes
Figure 3. (A–D) Changes in clinical characteristics. Data are adjusted means (95% confidence intervals) for each time point derived from
generalised linear models with repeated measures. Adjustments are made for the baseline value for the respective outcome variable. Blood pressure
values are also adjusted for medication load. Statistical significance at each follow-up time point generated from univariate analysis of variance,*
p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0005195.g003
Figure 4. (A–F) Changes in laboratory characteristics. Data are adjusted means (95% confidence intervals) for each time point derived from
generalised linear models with repeated measures. Adjustments are made for the baseline value for the respective outcome variable. Blood pressure
values are also adjusted for medication load. Statistical significance at each follow-up time point generated from univariate analysis of variance,*
p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0005195.g004
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hand, providing participants in the standard care arm of the trial
with information about lifestyle and health, activity logs, and
regular follow-up exams may have diluted differences between
groups.
We present data analysed on an ITT basis, which is a highly
conservative method for assessing the impact of an intervention.
We also used mixed-models incorporating all available data
without imputation of missing data points. Both methods yielded
similar results, highlighting the robustness of our findings.
At baseline we asked the participants ‘‘if the beneficial effects of
physical activity and drug treatment were the same, which method
would you prefer?’’ and ‘‘if both physical activity on prescription
and drug treatment were free of charge, which would you prefer?’’
The vast majority of our participants responded that they would
prefer the physical activity option and none opted for drug
therapy. This preference for physical activity as a form of
treatment may reflect the cultural emphasis on healthy living in
the north of Sweden. However, in both groups there was an
increased use of lipid and blood pressure lowering medication
during the study, which may reflect current treatment recommen-
dations that emphasise reaching specific target levels.
Although this intervention was not designed to specifically
promote smoking cessation, tobacco habits and the effects of
tobacco on health were discussed at the follow-up meetings. That
broad focus on healthy living may explain why more smokers quit
in the lifestyle than in the control group. In combination with the
reductions in waist circumference and systolic blood pressure
observed in this trial and increased exercise and overall physical
activity levels, the reductions in tobacco usage are likely to yield
continuing improvements in the health of our participants.
Our study addresses the important objective of translating the
findings from extensively resourced trials, which focussed on highly
selected populations and study settings, to a real-life setting where
resources are limited and the population is more heterogeneous.
However, an inherent limitation of studies that seek to do this is that
they suffer from lower internal validity. In this respect, the Bjo ¨rkna ¨s
study was not blinded and the intervention was less tightly
controlled and less well resourced than several previous studies. In
this study as in the DPP, only half of all eligible subjects were
randomized to treatment [47]. However, those who declined to
participate didnot differfromthosewho took part with respect toall
key characteristics. Because attrition rates were modest and we used
ITT analyses, our findings may be less prone to bias than some
other studies. Nonetheless, as indicated by the wide confidence
intervals for several traits, our study was underpowered to detect
small improvements in the clinical traits examined. Thus, some of
our findings may be prone to type 2 error.
Figure 5. (A–C) Changes in physical activity level. Proportion of participants reporting the level of each variable, total physical activity, leisure
time physical activity and exercise and ordered as follows: TPA; sedentary, minimally active, moderately active and very active. LTPA and exercise;
‘none’=0, ‘,30 min/day’=1, ‘30–60 min/day’=2, and ‘.60 min/day’=3. P values from general linear model repeated measures analysis.
doi:10.1371/journal.pone.0005195.g005
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In summary, a lifestyle intervention program applied in the
primary care setting beneficially impacts cardiovascular risk
profiles. These findings provide some of the first empirical
evidence that affordable programs of lifestyle intervention, which
can be widely prescribed effectively reduce risk factors for
cardiovascular disease in initially high-risk individuals. Our study
also shows that such interventions can be integrated within existing
health care infrastructures, at least in the Swedish setting. Studies
such as ours support a de-emphasis of the use of drug therapies in
favour of safer, more holistic, and more effective treatments
combining diet and exercise prescription.
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